NATHAN MARCHAND: Open Payments
NPI 1114020708 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 16 payments from 6 companies in 2025. Trend: 2023 $140 · 2024 $455 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $105 |
| Novo Nordisk Inc | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Amgen Inc. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: ELIQUIS, Wegovy, OTEZLA, AREXVY, TRELEGY ELLIPTA, BREZTRI, Rybelsus, FARXIGA.
Industry payments across TX — which companies pay providers there.
